Takeda to sell Brazil's Multilab to Novamed

5 April 2018 - Deborah Wilkes

Archived

Japan's Takeda Pharmaceutical is divesting its Brazilian generics and OTC company Multilab to Novamed for an undisclosed sum.

Click tags below for more information on topics:

Takeda

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: